These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28705644)

  • 61. Nutrition is medicine: dietary inhibition of hepcidin expression.
    McClung JP
    Br J Nutr; 2014 Apr; 111(7):1145-6. PubMed ID: 24503035
    [No Abstract]   [Full Text] [Related]  

  • 62. Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor.
    Ogiyama T; Yamaguchi M; Kurikawa N; Honzumi S; Terayama K; Nagaoka N; Yamamoto Y; Kimura T; Sugiyama D; Inoue SI
    Bioorg Med Chem; 2017 Sep; 25(17):4817-4828. PubMed ID: 28756012
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis.
    Hawula ZJ; Wallace DF; Subramaniam VN; Rishi G
    Pharmaceuticals (Basel); 2019 Nov; 12(4):. PubMed ID: 31775259
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepcidin Therapeutics.
    Katsarou A; Pantopoulos K
    Pharmaceuticals (Basel); 2018 Nov; 11(4):. PubMed ID: 30469435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives.
    Zhang SG; Liang CG; Zhang WH
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30373212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.
    Fukuda T; Ueda K; Ishiyama T; Goto R; Muramatsu S; Hashimoto M; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 May; 27(10):2148-2152. PubMed ID: 28377056
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
    Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5252-5257. PubMed ID: 29079471
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
    Fukuda T; Ishiyama T; Katagiri T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Baba D; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3333-3337. PubMed ID: 30217414
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo.
    Wallace DF; Subramaniam VN
    Int Immunol; 2015 Jun; 27(6):281-7. PubMed ID: 25568302
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
    Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3716-3722. PubMed ID: 28705644
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepcidin and IL-1β.
    Kanamori Y; Murakami M; Sugiyama M; Hashimoto O; Matsui T; Funaba M
    Vitam Horm; 2019; 110():143-156. PubMed ID: 30798809
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beyond anemia: hepcidin, monocytes and inflammation.
    Zhang X; Rovin BH
    Biol Chem; 2013 Feb; 394(2):231-8. PubMed ID: 23314535
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.